The Next Big Thing In Biotech: BIO CEO Conference
Feb 07, 2013 | 11:38 AM EST - 

Adam Feuerstein, Sr. Columnist for TheStreet, says the BIO CEO Conference is the next big thing in biotech.

Columnist Conversations

Market is flat as we approach midday which is not bad performance given the continued sell-off in Apple (AAPL)...
We sold out of our Netflix calls entered last week for a nice double...and rolled them up to a higher strike. ...
Just a quick add to my column on LONG. Why would Ctrip even look at this offer which values eLong at $650 mill...
Helene wrote --"If it gets broken and it's still heading up then it tends to act as very minor resistance." Th...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.